PF-Atlas › Clinical Trials › NCT01025713

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis

GS-9411 · Phase 1

Registry ID

NCT01025713

Phase

Phase 1

Status

Withdrawn

Drug / intervention

GS-9411

Sponsor

Gilead Sciences

Start

2009-12

About this trial

GS-9411 is evaluated in NCT01025713, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Gilead Sciences. Current status: Withdrawn.

View NCT01025713 on ClinicalTrials.gov →

Explore related

All GS-9411 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT01025713 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.